Triple-negative breast cancer: promising prognostic biomarkers currently in development

INTRODUCTION: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer associated with poor prognosis and limited treatment options. Validated prognostic and predictive biomarkers are needed to guide treatment decisions and prognostication. AREAS COVERED: In this review, we discus...

Descripción completa

Detalles Bibliográficos
Autores principales: Sukumar, Jasmine, Gast, Kelly, Quiroga, Dionisia, Lustberg, Maryam, Williams, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174647/
https://www.ncbi.nlm.nih.gov/pubmed/33198517
http://dx.doi.org/10.1080/14737140.2021.1840984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174647/
https://www.ncbi.nlm.nih.gov/pubmed/33198517
http://dx.doi.org/10.1080/14737140.2021.1840984

Ejemplares similares